- Home
- TIL vs EM Comparison
TIL vs EM Comparison
Compare TIL & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- EM
- Stock Information
- Founded
- TIL 2018
- EM 2017
- Country
- TIL United States
- EM China
- Employees
- TIL N/A
- EM N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- EM Other Consumer Services
- Sector
- TIL Health Care
- EM Consumer Discretionary
- Exchange
- TIL Nasdaq
- EM Nasdaq
- Market Cap
- TIL 230.1M
- EM 273.0M
- IPO Year
- TIL 2021
- EM 2021
- Fundamental
- Price
- TIL $27.56
- EM $1.11
- Analyst Decision
- TIL Buy
- EM Hold
- Analyst Count
- TIL 5
- EM 1
- Target Price
- TIL $119.00
- EM $1.25
- AVG Volume (30 Days)
- TIL 503.4K
- EM 54.1K
- Earning Date
- TIL 08-12-2025
- EM 07-01-2025
- Dividend Yield
- TIL N/A
- EM N/A
- EPS Growth
- TIL N/A
- EM N/A
- EPS
- TIL N/A
- EM N/A
- Revenue
- TIL N/A
- EM $259,541,587.00
- Revenue This Year
- TIL N/A
- EM $3.30
- Revenue Next Year
- TIL N/A
- EM $5.26
- P/E Ratio
- TIL N/A
- EM N/A
- Revenue Growth
- TIL N/A
- EM N/A
- 52 Week Low
- TIL $9.62
- EM $0.50
- 52 Week High
- TIL $92.00
- EM $1.17
- Technical
- Relative Strength Index (RSI)
- TIL 51.84
- EM 54.87
- Support Level
- TIL $27.01
- EM $1.09
- Resistance Level
- TIL $42.79
- EM $1.12
- Average True Range (ATR)
- TIL 5.01
- EM 0.03
- MACD
- TIL -1.00
- EM 0.00
- Stochastic Oscillator
- TIL 9.82
- EM 58.75
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.